Jay W. Mason, M.D.

Chief Medical Officer

Spaulding Clinical, LLC

Talk to Jay about these topics and more:

  • Understanding cardiac safety requirements, including protocol design 
  • Sponsor support at FDA meetings 
  • Early phase development 
  • Working with data and safety monitoring boards 
  • Cardiac arrhythmias and electrophysiology  

Cardiovascular

Clinical Data

Clinical Trials

Contract Research Organization (CRO)

FDA

M.D.

Phase I/Early Phase Research 

Preclinical

Regulatory

Safety

View Expert

Cassandra Erato, MSN

Chief Executive Officer

Spaulding Clinical, LLC

Talk to Cassie about these topics and more:

  • Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct 
  • Efficiencies and guidance in running Phase 1 of clinical development  
  • Understanding cardiac safety requirements and the best cost-saving methods 
  • Developing new service programs as needs emerge 
  • Rapid operational scaling/growth, strategic planning, and recapitalization 

Biostatistics

Cardiovascular

CEO

Clinical Data

Clinical Trials

Contract Research Organization (CRO)

Medical Writing

Paperless

Pharmacology 

Phase I/Early Phase Research 

Preclinical

Regulatory

Strategic Planning

View Expert